Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/8/2025

Treatment of Facial Psoriasis in Children

Introduction to Treatment Guidelines

  • The American Academy of Dermatology recommends tacrolimus 0.1% ointment as the first-line treatment for facial psoriasis in pediatric patients due to its efficacy and safety profile 1, 2

Rationale for Tacrolimus as First-Line Therapy

  • The American Academy of Dermatology-National Psoriasis Foundation guidelines recommend topical calcineurin inhibitors, such as tacrolimus, as the preferred first-line therapy for psoriasis of the face, genitalia, and body folds in pediatric patients, highlighting their preference over topical corticosteroids due to lower risks of adverse effects 1, 2

Evidence Supporting Tacrolimus for Facial Psoriasis

  • Tacrolimus 0.1% ointment has shown rapid efficacy, with complete clearance of facial psoriasis achieved within 72 hours in some cases, and sustained response, with clearance reported within 2 weeks in a retrospective review of 12 children 1, 2
  • Tacrolimus 0.1% has demonstrated good tolerability in children ages 6-15 years with facial or inverse psoriasis, with 88% of patients achieving clearance or excellent improvement within 30 days 1, 2

Application Protocol

  • The recommended application protocol for tacrolimus 0.1% ointment is twice daily to affected facial areas until clearance is achieved, with continuation of treatment for at least 30 days to assess full response 1, 2

Critical Safety Considerations

  • High-potency or ultra-high-potency corticosteroids should be avoided on facial skin in children due to increased risk of skin atrophy and HPA axis suppression, emphasizing the need for careful selection of topical treatments 1, 3
  • Regular follow-up with a dermatologist is essential to monitor treatment response and prevent adverse effects, particularly in pediatric patients 1

Maintenance Strategy

  • Once clearance is achieved, consideration should be given to twice-weekly application of tacrolimus to previously affected facial areas to prevent relapses, alongside emphasis on regular emollient use to maintain skin barrier function 1, 2, 5